Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review

Dermatomyositis (DM) is defined as an autoimmune inflammatory disease that affects the skin, the blood vessels and the muscles. It typically presents with erythema affecting mostly the eyes and the hands as well as proximal muscle weakness. It has been also correlated with various types of cancer, i...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Victoria Psomiadou, Ioannis D. Gkegkes, Christos Iavazzo
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	dermatomyositis polymyositis ovarian cancer paraneoplastic syndrome. Medicine R
Acceso en línea:	https://doaj.org/article/127a90a1e8424c01b73398c831bd56d7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:127a90a1e8424c01b73398c831bd56d7
record_format	dspace
spelling	oai:doaj.org-article:127a90a1e8424c01b73398c831bd56d72021-12-02T17:45:53ZDermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review1428-25261897-430910.5114/wo.2020.102814https://doaj.org/article/127a90a1e8424c01b73398c831bd56d72021-01-01T00:00:00Zhttps://www.termedia.pl/Dermatomyositis-and-or-polymyositis-as-a-paraneoplastic-manifestation-of-ovarian-cancer-a-systematic-review,3,43073,1,1.htmlhttps://doaj.org/toc/1428-2526https://doaj.org/toc/1897-4309Dermatomyositis (DM) is defined as an autoimmune inflammatory disease that affects the skin, the blood vessels and the muscles. It typically presents with erythema affecting mostly the eyes and the hands as well as proximal muscle weakness. It has been also correlated with various types of cancer, including ovarian cancer. A systematic PubMed and Scopus search was conducted. A total of 110 women were included in our review. The median age of the patients was 52.5 years (8–85). The most frequent histological type of malignancy was epithelial (87 cases, 79.1%) and in only one patient (0.9%) DM was co-existing with a cancer recurrence. A clinical diagnosis of DM or PM preceded the diagnosis of ovarian cancer in 69.1% (76/110), while paraneoplastic DM after the diagnosis of ovarian cancer was reported in 31% (34/110). Serum antibodies were present in 22.5% (25/110) and the median creatine kinase during first evaluation was 886 (56.6–16,596). Postoperative improvement of the symptoms was observed in 24.6% (27/110) while also 24.6% (27/110) needed post-treatment rheumatological management. Neoadjuvant chemotherapy or radiotherapy was necessary in 58.2% (64/110) and a cancer recurrence was identified in 28.2% (31/110), with a median follow up of 24.5 months (5–210). Finally, 52 (47.3%) deaths were reported in a median follow-up period of 16 months (0–210). It is crucial that DM patients should receive a thorough evaluation for ovarian cancer, among other malignancies, encompassing an abdominal CT or MRI scan and serum Ca-125 marker measurements. Treatment of ovarian cancer is usually accompanied by remission of DM symptoms in most of the cases.Victoria PsomiadouIoannis D. GkegkesChristos IavazzoTermedia Publishing Housearticledermatomyositis polymyositis ovarian cancer paraneoplastic syndrome.MedicineRENContemporary Oncology, Vol 24, Iss 4, Pp 252-257 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	dermatomyositis polymyositis ovarian cancer paraneoplastic syndrome. Medicine R
spellingShingle	dermatomyositis polymyositis ovarian cancer paraneoplastic syndrome. Medicine R Victoria Psomiadou Ioannis D. Gkegkes Christos Iavazzo Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
description	Dermatomyositis (DM) is defined as an autoimmune inflammatory disease that affects the skin, the blood vessels and the muscles. It typically presents with erythema affecting mostly the eyes and the hands as well as proximal muscle weakness. It has been also correlated with various types of cancer, including ovarian cancer. A systematic PubMed and Scopus search was conducted. A total of 110 women were included in our review. The median age of the patients was 52.5 years (8–85). The most frequent histological type of malignancy was epithelial (87 cases, 79.1%) and in only one patient (0.9%) DM was co-existing with a cancer recurrence. A clinical diagnosis of DM or PM preceded the diagnosis of ovarian cancer in 69.1% (76/110), while paraneoplastic DM after the diagnosis of ovarian cancer was reported in 31% (34/110). Serum antibodies were present in 22.5% (25/110) and the median creatine kinase during first evaluation was 886 (56.6–16,596). Postoperative improvement of the symptoms was observed in 24.6% (27/110) while also 24.6% (27/110) needed post-treatment rheumatological management. Neoadjuvant chemotherapy or radiotherapy was necessary in 58.2% (64/110) and a cancer recurrence was identified in 28.2% (31/110), with a median follow up of 24.5 months (5–210). Finally, 52 (47.3%) deaths were reported in a median follow-up period of 16 months (0–210). It is crucial that DM patients should receive a thorough evaluation for ovarian cancer, among other malignancies, encompassing an abdominal CT or MRI scan and serum Ca-125 marker measurements. Treatment of ovarian cancer is usually accompanied by remission of DM symptoms in most of the cases.
format	article
author	Victoria Psomiadou Ioannis D. Gkegkes Christos Iavazzo
author_facet	Victoria Psomiadou Ioannis D. Gkegkes Christos Iavazzo
author_sort	Victoria Psomiadou
title	Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
title_short	Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
title_full	Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
title_fullStr	Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
title_full_unstemmed	Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
title_sort	dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
publisher	Termedia Publishing House
publishDate	2021
url	https://doaj.org/article/127a90a1e8424c01b73398c831bd56d7
work_keys_str_mv	AT victoriapsomiadou dermatomyositisandorpolymyositisasaparaneoplasticmanifestationofovariancancerasystematicreview AT ioannisdgkegkes dermatomyositisandorpolymyositisasaparaneoplasticmanifestationofovariancancerasystematicreview AT christosiavazzo dermatomyositisandorpolymyositisasaparaneoplasticmanifestationofovariancancerasystematicreview
_version_	1718379512008278016

Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review

Ejemplares similares